| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 11/19/2009 | WO2009140089A2 Sulfone compounds which modulate the cb2 receptor |
| 11/19/2009 | US20090286944 Select phenol-heterocycle ligands, metal complexes formed therefrom, and their uses as catalysts |
| 11/19/2009 | US20090286841 Certain chemical entities, compositions, and methods |
| 11/19/2009 | US20090286837 Oxadiazole compounds as urokinase inhibitors |
| 11/19/2009 | CA2724232A1 Sulfone compounds which modulate the cb2 receptor |
| 11/18/2009 | CN101580497A Statins antilipemic drugs furazan nitroxides derivates and preparation method thereof |
| 11/17/2009 | US7618981 Imidazopyridinyl-benzamide anti-cancer agents |
| 11/12/2009 | WO2009137657A1 2-aryl glycinamide derivatives |
| 11/12/2009 | WO2009137251A2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings |
| 11/12/2009 | CA2721433A1 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings |
| 11/11/2009 | CN100558697C Cycloalkyl inhibitors of potassium channel function |
| 11/05/2009 | US20090275620 Substituted 5- phenylamino- 1, 3, 4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 11/04/2009 | EP1651642B1 Pna monomer and precursor |
| 11/04/2009 | EP1444739B1 Light emitting device and compounds for use therein |
| 10/29/2009 | WO2009131954A2 Compounds, compositions and methods comprising oxadiazole derivatives |
| 10/29/2009 | WO2009131090A1 Amino acid compound |
| 10/29/2009 | US20090270627 4-Ethynyl (1,2-dicyanobenzene)-4'-Ethynylphenyl-1(4,5-dicyanobenzene); 1,4-Bis(4-pyridyl)butadiyne; 4-ethynyl(pyridine)-4'-ethynylnaphthalene-1-pyridine; self-assembled mono-, multilayers/ supramolecular objects; three-terminal devices; logic switches;nanoelectronic ; computers; wires; dielectrics |
| 10/29/2009 | US20090270440 Bioavailability of active substances having an amidine function in medicaments |
| 10/27/2009 | US7608632 Sulfonamide inhibitors of aspartyl protease |
| 10/27/2009 | US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
| 10/22/2009 | WO2009127723A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
| 10/22/2009 | US20090264482 Chemical compounds |
| 10/22/2009 | US20090264481 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives |
| 10/22/2009 | CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
| 10/22/2009 | CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 10/20/2009 | US7605171 (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists |
| 10/20/2009 | US7605163 Benzoyl-piperazine derivatives |
| 10/15/2009 | WO2009125853A1 Homocysteine synthase inhibitor |
| 10/15/2009 | WO2009105214A3 Selective androgen receptor modulators |
| 10/15/2009 | US20090258868 Heterocyclic aspartyl protease inhibitors |
| 10/15/2009 | CA2725425A1 Homocysteine synthase inhibitor |
| 10/13/2009 | CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
| 10/08/2009 | WO2009123316A1 Heterocyclic derivative and use thereof |
| 10/08/2009 | WO2008107501A8 Composition for treating infectious diseases caused by helicobacter |
| 10/08/2009 | US20090253761 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 10/08/2009 | US20090253758 Selective androgen receptor modulators |
| 10/08/2009 | US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use |
| 10/08/2009 | CA2720343A1 Heterocyclic derivative and use thereof |
| 10/07/2009 | CN101550111A Preparation method of 2,5-bichlorphenyl-1,3,4-furodiazole |
| 10/06/2009 | US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist; |
| 10/06/2009 | US7598391 Heteroaryl-ureas and their use as glucokinase activators |
| 10/06/2009 | US7598389 Silylated carboxamides |
| 10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 09/24/2009 | WO2009117421A2 Heterocyclic modulators of gpr119 for treatment of disease |
| 09/24/2009 | US20090239909 Treatment of metabolic syndrome with lactams |
| 09/24/2009 | US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/23/2009 | EP2102176A2 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 09/23/2009 | EP2102162A1 Phenylic derivatives and use thereof as drugs |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | CN101541770A Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
| 09/23/2009 | CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 09/22/2009 | US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) |
| 09/22/2009 | US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists |
| 09/17/2009 | WO2009067493A3 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders |
| 09/16/2009 | EP2099741A2 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| 09/16/2009 | CN101535284A Processes for the preparation of 1,2,4-oxadiazole benzoic acids |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540534C N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 09/15/2009 | US7589113 Substituted oxadiazole compounds and their use as opioid receptor ligands |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/11/2009 | WO2009109904A1 Novel aminomethyl benzene derivatives |
| 09/11/2009 | CA2715317A1 Novel aminomethyl benzene derivatives |
| 09/10/2009 | US20090227641 Cycloalkylamino acid derivatives |
| 09/10/2009 | US20090227640 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090223401 Lead-free primers |
| 09/09/2009 | EP2097397A1 Tetralin analogs having sphingosine 1-phosphate agonist activity |
| 09/09/2009 | EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/03/2009 | US20090221834 Synthesis of 5-Beta-Keto-1,2,4-Oxadiazoles and Conversion of 5-Beta-Keto-1,2,4 Oxadiazoles to N-Pyrazolyl Amidoximes |
| 09/03/2009 | US20090221442 Substrates and screening methods for transport proteins |
| 09/02/2009 | CN101522646A Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties |
| 09/02/2009 | CN101522645A Phenyl derivatives and their use as immunomodulators |
| 09/02/2009 | CN101519385A Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582663 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 08/27/2009 | WO2009105214A2 Selective androgen receptor modulators |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215779 Oxadiazole derivatives as dgat inhibitors |
| 08/27/2009 | DE102008010221A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma |
| 08/27/2009 | CA2716320A1 Selective androgen receptor modulators |
| 08/26/2009 | EP2093220A2 Inhibitors of fatty acid amide hydrolase |
| 08/20/2009 | WO2009101082A1 Substituted sulfonic acid amide compounds |
| 08/20/2009 | WO2009074733A3 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 08/19/2009 | EP1838304B1 Heterocyclic aspartyl protease inhibitors |
| 08/19/2009 | EP1635824B1 5-membered heterocycle-based p-38 inhibitors |
| 08/19/2009 | EP1513802B1 Alpha-sulfonylamino-acetonitriles |
| 08/19/2009 | CN101508682A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/18/2009 | US7576220 Method of producing 1,2,4-oxadiazole derivatives |
| 08/18/2009 | US7576109 5-{4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-3H-[1,3,4]oxadiazol-2-one; agonists and antiagonists; demylination diseases; metabolic diseases; antidiabetic agents (type 2); syndrom X; asthma; osteoarthritis; lupus; antiinflammatory agents; cardiovascular disorders; cachexia |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203752 Compounds for nonsense suppression, and methods for their use |
| 08/12/2009 | EP1601354A4 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 08/11/2009 | US7572920 Benzimidazole derivative and use as a II receptor antagonist |